Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO16234 | Orgyia australis postica | Species | Lymantriidae | Eukaryota | UNPD* | |||
NPO15440 | Chamaemelum nobile | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO22583 | Daedaleopsis confragosa | Species | Coriolaceae | Eukaryota | UNPD* | |||
NPO24284 | Hypoestes serpens | Species | Acanthaceae | Eukaryota | UNPD* | |||
NPO24329 | Primula farinosa | Species | Primulaceae | Eukaryota | UNPD* | |||
NPO20617 | Tilletia laevis | Species | Tilletiaceae | Eukaryota | UNPD* | |||
NPO24173 | Plutella xylostella | Species | Plutellidae | Eukaryota | UNPD* | |||
NPO17647 | Schkuhria multiflora | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO23957 | Helleborus caucasicus | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO24045 | Lespedeza homoloba | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO23916 | Anthocleista grandiflora | Species | Gentianaceae | Eukaryota | UNPD* | |||
NPO18557 | Epicoccum nigrum | Species | Didymellaceae | Eukaryota | UNPD* | |||
NPO2688 | Pericarpium pyri | NA | NA | NA | TCMID* | |||
NPO24216 | Lolium perenne | Species | Poaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT711 | Individual Protein | Aldose reductase | Bos taurus | Inhibition | = | 0 | % | 10354396 |
NPT581 | Individual Protein | Cyclooxygenase-2 | Mus musculus | Inhibition | = | 45 | % | 14980657 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | Ki | = | 1900 | nM | 10543878 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 2170 | nM | 8576921 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 6200 | nM | 8576921 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 65900 | nM | 16722653 |
NPT2 | Others | Unspecified | Inhibition | = | 17 | % | 17624791 | |
NPT2 | Others | Unspecified | Activity | = | 14.6 | % | 2959755 | |
NPT2 | Others | Unspecified | Activity | = | 95.7 | % | 2959755 | |
NPT2 | Others | Unspecified | Activity | = | 98.9 | % | 2959755 | |
NPT2 | Others | Unspecified | IC50 | = | 425 | nM | 2959755 | |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 20 | ug/ml | 469554 |
NPT1044 | Individual Protein | DNA topoisomerase II alpha | Homo sapiens | Activity | < | 50 | % | 7769390 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | IC50 | = | 300 | nM | 19592245 |
NPT35 | Others | n.a. | Activity | = | 11.6 | ug/ml | 19944611 | |
NPT2 | Others | Unspecified | IC50 | > | 1000000 | nM | 20097567 | |
NPT1338 | Individual Protein | Sialidase 2 | Homo sapiens | IC50 | > | 1000000 | nM | 20097567 |
NPT2 | Others | Unspecified | Potency | = | 316.2 | nM | PubChem BioAssay data set | |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PubChem BioAssay data set | |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 115.9 | % | 21907578 | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 8436.8 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 2310.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT1 | Others | Radical scavenging activity | Inhibition | = | 0.6 | % | 10.1007/s00044-007-9060-5 | |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 310 | nM | 23600958 |
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | IC50 | = | 4030 | nM | 23600958 |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | IC50 | = | 831.76 | nM | 23611768 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | IC50 | = | 840 | nM | 23611768 |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 23871908 | |
NPT2 | Others | Unspecified | IC50 | = | 96000 | nM | 23871908 | |
NPT2 | Others | Unspecified | Inhibition | = | 30.1 | % | 23871908 | |
NPT2 | Others | Unspecified | Activity | > | 98 | % | 23871908 | |
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1122 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT1 | Others | Radical scavenging activity | IC50 | = | 23.8 | ug/ml | 24793879 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 88.8 | % | 24793879 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 28.6 | % | 24793879 |
NPT111 | Cell Line | K562 | Homo sapiens | Activity | = | 26.7 | % | 24793879 |
NPT2 | Others | Unspecified | Potency | 5623.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC197425 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9919 | High Similarity | NPC39753 |
0.9919 | High Similarity | NPC115998 |
0.9839 | High Similarity | NPC137264 |
0.976 | High Similarity | NPC113006 |
0.9683 | High Similarity | NPC128216 |
0.9606 | High Similarity | NPC50898 |
0.9606 | High Similarity | NPC78540 |
0.9606 | High Similarity | NPC274121 |
0.9606 | High Similarity | NPC57601 |
0.9606 | High Similarity | NPC213216 |
0.9531 | High Similarity | NPC172262 |
0.9531 | High Similarity | NPC248872 |
0.952 | High Similarity | NPC187907 |
0.9431 | High Similarity | NPC193805 |
0.9385 | High Similarity | NPC187432 |
0.9385 | High Similarity | NPC256042 |
0.9385 | High Similarity | NPC29353 |
0.9385 | High Similarity | NPC234133 |
0.9385 | High Similarity | NPC124784 |
0.9385 | High Similarity | NPC47815 |
0.9385 | High Similarity | NPC473887 |
0.9385 | High Similarity | NPC194281 |
0.9385 | High Similarity | NPC116775 |
0.9385 | High Similarity | NPC216361 |
0.9385 | High Similarity | NPC281917 |
0.9385 | High Similarity | NPC13408 |
0.9385 | High Similarity | NPC231772 |
0.9385 | High Similarity | NPC127447 |
0.936 | High Similarity | NPC22783 |
0.936 | High Similarity | NPC41721 |
0.9313 | High Similarity | NPC250266 |
0.9313 | High Similarity | NPC266597 |
0.9313 | High Similarity | NPC299379 |
0.9313 | High Similarity | NPC228661 |
0.9308 | High Similarity | NPC239495 |
0.9308 | High Similarity | NPC9985 |
0.9242 | High Similarity | NPC201395 |
0.9219 | High Similarity | NPC5515 |
0.9219 | High Similarity | NPC270369 |
0.9173 | High Similarity | NPC78913 |
0.9173 | High Similarity | NPC18260 |
0.9173 | High Similarity | NPC241838 |
0.9173 | High Similarity | NPC143799 |
0.9173 | High Similarity | NPC55018 |
0.9173 | High Similarity | NPC301217 |
0.9173 | High Similarity | NPC152042 |
0.9173 | High Similarity | NPC303633 |
0.9173 | High Similarity | NPC96565 |
0.9173 | High Similarity | NPC220062 |
0.9173 | High Similarity | NPC216978 |
0.9167 | High Similarity | NPC13768 |
0.9167 | High Similarity | NPC84585 |
0.9167 | High Similarity | NPC243083 |
0.9167 | High Similarity | NPC476480 |
0.9167 | High Similarity | NPC79943 |
0.9167 | High Similarity | NPC287246 |
0.9167 | High Similarity | NPC12296 |
0.9167 | High Similarity | NPC290291 |
0.9167 | High Similarity | NPC275055 |
0.9167 | High Similarity | NPC32441 |
0.9167 | High Similarity | NPC295261 |
0.9167 | High Similarity | NPC296490 |
0.9167 | High Similarity | NPC107586 |
0.9147 | High Similarity | NPC31872 |
0.9147 | High Similarity | NPC473584 |
0.9147 | High Similarity | NPC475589 |
0.9104 | High Similarity | NPC103904 |
0.9104 | High Similarity | NPC305355 |
0.9104 | High Similarity | NPC146679 |
0.9104 | High Similarity | NPC281207 |
0.9104 | High Similarity | NPC230285 |
0.9104 | High Similarity | NPC59951 |
0.9104 | High Similarity | NPC269652 |
0.9104 | High Similarity | NPC475680 |
0.9104 | High Similarity | NPC241100 |
0.9104 | High Similarity | NPC270883 |
0.9104 | High Similarity | NPC103342 |
0.9104 | High Similarity | NPC172986 |
0.9104 | High Similarity | NPC159275 |
0.9104 | High Similarity | NPC184536 |
0.9104 | High Similarity | NPC261227 |
0.9098 | High Similarity | NPC99333 |
0.9098 | High Similarity | NPC188947 |
0.9098 | High Similarity | NPC329225 |
0.9098 | High Similarity | NPC280284 |
0.9098 | High Similarity | NPC18457 |
0.9098 | High Similarity | NPC472460 |
0.9098 | High Similarity | NPC118813 |
0.9098 | High Similarity | NPC147686 |
0.9091 | High Similarity | NPC240593 |
0.9077 | High Similarity | NPC25937 |
0.9077 | High Similarity | NPC10971 |
0.9037 | High Similarity | NPC156590 |
0.9037 | High Similarity | NPC90582 |
0.9037 | High Similarity | NPC147688 |
0.9037 | High Similarity | NPC282300 |
0.9037 | High Similarity | NPC205006 |
0.9037 | High Similarity | NPC14871 |
0.9037 | High Similarity | NPC118840 |
0.9037 | High Similarity | NPC110969 |
0.9037 | High Similarity | NPC262094 |
0.9037 | High Similarity | NPC136840 |
0.9037 | High Similarity | NPC64908 |
0.903 | High Similarity | NPC265871 |
0.903 | High Similarity | NPC261234 |
0.903 | High Similarity | NPC217186 |
0.903 | High Similarity | NPC225153 |
0.903 | High Similarity | NPC274784 |
0.903 | High Similarity | NPC20709 |
0.903 | High Similarity | NPC150648 |
0.903 | High Similarity | NPC222342 |
0.903 | High Similarity | NPC316480 |
0.903 | High Similarity | NPC329203 |
0.903 | High Similarity | NPC310135 |
0.903 | High Similarity | NPC53181 |
0.9023 | High Similarity | NPC254841 |
0.9023 | High Similarity | NPC160972 |
0.9023 | High Similarity | NPC188879 |
0.9015 | High Similarity | NPC151113 |
0.9015 | High Similarity | NPC39426 |
0.9015 | High Similarity | NPC234560 |
0.9008 | High Similarity | NPC223457 |
0.9008 | High Similarity | NPC108113 |
0.9008 | High Similarity | NPC93756 |
0.9 | High Similarity | NPC308037 |
0.9 | High Similarity | NPC64359 |
0.9 | High Similarity | NPC284424 |
0.9 | High Similarity | NPC313618 |
0.9 | High Similarity | NPC475009 |
0.9 | High Similarity | NPC278556 |
0.9 | High Similarity | NPC186097 |
0.9 | High Similarity | NPC475008 |
0.8992 | High Similarity | NPC228184 |
0.8992 | High Similarity | NPC12694 |
0.8971 | High Similarity | NPC11561 |
0.8971 | High Similarity | NPC78803 |
0.8971 | High Similarity | NPC214236 |
0.8971 | High Similarity | NPC217083 |
0.8971 | High Similarity | NPC293852 |
0.8971 | High Similarity | NPC200694 |
0.8971 | High Similarity | NPC226636 |
0.8971 | High Similarity | NPC62840 |
0.8971 | High Similarity | NPC473042 |
0.8971 | High Similarity | NPC1534 |
0.8971 | High Similarity | NPC59739 |
0.8971 | High Similarity | NPC299080 |
0.8963 | High Similarity | NPC235239 |
0.8963 | High Similarity | NPC110228 |
0.8963 | High Similarity | NPC284550 |
0.8963 | High Similarity | NPC76445 |
0.8963 | High Similarity | NPC145673 |
0.8963 | High Similarity | NPC188243 |
0.8963 | High Similarity | NPC69769 |
0.8963 | High Similarity | NPC150522 |
0.8963 | High Similarity | NPC6407 |
0.8963 | High Similarity | NPC129853 |
0.8955 | High Similarity | NPC124269 |
0.8955 | High Similarity | NPC276905 |
0.8947 | High Similarity | NPC235428 |
0.8947 | High Similarity | NPC87545 |
0.8939 | High Similarity | NPC125920 |
0.8931 | High Similarity | NPC257756 |
0.8931 | High Similarity | NPC212631 |
0.8931 | High Similarity | NPC129132 |
0.8931 | High Similarity | NPC101294 |
0.8931 | High Similarity | NPC473655 |
0.8931 | High Similarity | NPC87231 |
0.8931 | High Similarity | NPC205468 |
0.8915 | High Similarity | NPC60558 |
0.8905 | High Similarity | NPC24821 |
0.8905 | High Similarity | NPC11700 |
0.8905 | High Similarity | NPC293053 |
0.8905 | High Similarity | NPC470216 |
0.8905 | High Similarity | NPC279121 |
0.8905 | High Similarity | NPC9117 |
0.8905 | High Similarity | NPC219915 |
0.8905 | High Similarity | NPC212932 |
0.8905 | High Similarity | NPC38219 |
0.8905 | High Similarity | NPC190637 |
0.8897 | High Similarity | NPC324386 |
0.8897 | High Similarity | NPC3188 |
0.8897 | High Similarity | NPC312391 |
0.8897 | High Similarity | NPC213322 |
0.8897 | High Similarity | NPC103362 |
0.8897 | High Similarity | NPC4743 |
0.8889 | High Similarity | NPC140890 |
0.8889 | High Similarity | NPC93730 |
0.8881 | High Similarity | NPC294409 |
0.8881 | High Similarity | NPC116632 |
0.8881 | High Similarity | NPC303644 |
0.8881 | High Similarity | NPC162680 |
0.8881 | High Similarity | NPC181124 |
0.8881 | High Similarity | NPC7013 |
0.8881 | High Similarity | NPC212767 |
0.8881 | High Similarity | NPC209560 |
0.8881 | High Similarity | NPC332594 |
0.8872 | High Similarity | NPC60667 |
0.8872 | High Similarity | NPC242712 |
0.8864 | High Similarity | NPC28753 |
0.8864 | High Similarity | NPC337373 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC197425 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9167 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9167 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9098 | High Similarity | NPD1549 | Phase 2 |
0.9015 | High Similarity | NPD1510 | Phase 2 |
0.9 | High Similarity | NPD1240 | Approved |
0.8905 | High Similarity | NPD1511 | Approved |
0.8864 | High Similarity | NPD1607 | Approved |
0.8841 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8806 | High Similarity | NPD1551 | Phase 2 |
0.8777 | High Similarity | NPD1512 | Approved |
0.875 | High Similarity | NPD1203 | Approved |
0.8705 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8686 | High Similarity | NPD3750 | Approved |
0.8667 | High Similarity | NPD2796 | Approved |
0.8451 | Intermediate Similarity | NPD5403 | Approved |
0.844 | Intermediate Similarity | NPD5401 | Approved |
0.8438 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.8413 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8372 | Intermediate Similarity | NPD9717 | Approved |
0.8356 | Intermediate Similarity | NPD2801 | Approved |
0.8321 | Intermediate Similarity | NPD3748 | Approved |
0.8295 | Intermediate Similarity | NPD422 | Phase 1 |
0.8288 | Intermediate Similarity | NPD1934 | Approved |
0.8286 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8284 | Intermediate Similarity | NPD2313 | Discontinued |
0.8276 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8273 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8239 | Intermediate Similarity | NPD6799 | Approved |
0.8231 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8219 | Intermediate Similarity | NPD7411 | Suspended |
0.8188 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD2797 | Approved |
0.8176 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.812 | Intermediate Similarity | NPD2798 | Approved |
0.8106 | Intermediate Similarity | NPD3225 | Approved |
0.8085 | Intermediate Similarity | NPD1243 | Approved |
0.8067 | Intermediate Similarity | NPD3749 | Approved |
0.8067 | Intermediate Similarity | NPD7075 | Discontinued |
0.8054 | Intermediate Similarity | NPD5402 | Approved |
0.8041 | Intermediate Similarity | NPD6801 | Discontinued |
0.8015 | Intermediate Similarity | NPD1610 | Phase 2 |
0.8015 | Intermediate Similarity | NPD3268 | Approved |
0.8015 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8 | Intermediate Similarity | NPD3882 | Suspended |
0.7987 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD7819 | Suspended |
0.7969 | Intermediate Similarity | NPD9493 | Approved |
0.7958 | Intermediate Similarity | NPD2800 | Approved |
0.7943 | Intermediate Similarity | NPD2344 | Approved |
0.7933 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7929 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7917 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7905 | Intermediate Similarity | NPD6599 | Discontinued |
0.7879 | Intermediate Similarity | NPD1201 | Approved |
0.7872 | Intermediate Similarity | NPD6100 | Approved |
0.7872 | Intermediate Similarity | NPD6099 | Approved |
0.7832 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7808 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7801 | Intermediate Similarity | NPD2799 | Discontinued |
0.7778 | Intermediate Similarity | NPD3267 | Approved |
0.7778 | Intermediate Similarity | NPD3266 | Approved |
0.7771 | Intermediate Similarity | NPD3818 | Discontinued |
0.777 | Intermediate Similarity | NPD943 | Approved |
0.7756 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7756 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7756 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7756 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7754 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7754 | Intermediate Similarity | NPD411 | Approved |
0.7746 | Intermediate Similarity | NPD2935 | Discontinued |
0.7724 | Intermediate Similarity | NPD2309 | Approved |
0.7722 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD7054 | Approved |
0.7718 | Intermediate Similarity | NPD3226 | Approved |
0.7714 | Intermediate Similarity | NPD1933 | Approved |
0.7714 | Intermediate Similarity | NPD447 | Suspended |
0.7703 | Intermediate Similarity | NPD920 | Approved |
0.7692 | Intermediate Similarity | NPD2346 | Discontinued |
0.7687 | Intermediate Similarity | NPD1608 | Approved |
0.7677 | Intermediate Similarity | NPD6959 | Discontinued |
0.7676 | Intermediate Similarity | NPD7033 | Discontinued |
0.7673 | Intermediate Similarity | NPD7472 | Approved |
0.766 | Intermediate Similarity | NPD6651 | Approved |
0.7655 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD1470 | Approved |
0.7643 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7625 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7619 | Intermediate Similarity | NPD74 | Approved |
0.7619 | Intermediate Similarity | NPD9266 | Approved |
0.7609 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7597 | Intermediate Similarity | NPD1241 | Discontinued |
0.7591 | Intermediate Similarity | NPD1019 | Discontinued |
0.7589 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7582 | Intermediate Similarity | NPD4288 | Approved |
0.7578 | Intermediate Similarity | NPD7251 | Discontinued |
0.7562 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7556 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7554 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7552 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.754 | Intermediate Similarity | NPD9267 | Approved |
0.754 | Intermediate Similarity | NPD9264 | Approved |
0.754 | Intermediate Similarity | NPD9263 | Approved |
0.7536 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD7808 | Phase 3 |
0.75 | Intermediate Similarity | NPD4749 | Approved |
0.75 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7481 | Intermediate Similarity | NPD1535 | Discovery |
0.7469 | Intermediate Similarity | NPD6559 | Discontinued |
0.7463 | Intermediate Similarity | NPD17 | Approved |
0.7444 | Intermediate Similarity | NPD9545 | Approved |
0.7424 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD5953 | Discontinued |
0.7405 | Intermediate Similarity | NPD6232 | Discontinued |
0.7403 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7394 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD1613 | Approved |
0.7391 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7391 | Intermediate Similarity | NPD1164 | Approved |
0.7389 | Intermediate Similarity | NPD5494 | Approved |
0.7376 | Intermediate Similarity | NPD3764 | Approved |
0.7375 | Intermediate Similarity | NPD7473 | Discontinued |
0.7357 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD2654 | Approved |
0.7333 | Intermediate Similarity | NPD2532 | Approved |
0.7333 | Intermediate Similarity | NPD2534 | Approved |
0.7333 | Intermediate Similarity | NPD2533 | Approved |
0.7329 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD919 | Approved |
0.7323 | Intermediate Similarity | NPD968 | Approved |
0.7313 | Intermediate Similarity | NPD1894 | Discontinued |
0.7312 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7244 | Intermediate Similarity | NPD9697 | Approved |
0.7233 | Intermediate Similarity | NPD1247 | Approved |
0.7226 | Intermediate Similarity | NPD6844 | Discontinued |
0.7222 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD9261 | Approved |
0.7222 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7219 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD4662 | Approved |
0.7219 | Intermediate Similarity | NPD4661 | Approved |
0.7211 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7174 | Intermediate Similarity | NPD3972 | Approved |
0.7161 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD7390 | Discontinued |
0.7143 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7143 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD9281 | Approved |
0.7134 | Intermediate Similarity | NPD2296 | Approved |
0.7134 | Intermediate Similarity | NPD1729 | Discontinued |
0.7133 | Intermediate Similarity | NPD6798 | Discontinued |
0.7133 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7103 | Intermediate Similarity | NPD230 | Phase 1 |
0.7097 | Intermediate Similarity | NPD6585 | Discontinued |
0.7095 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7093 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7093 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7091 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.708 | Intermediate Similarity | NPD1778 | Approved |
0.7073 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7071 | Intermediate Similarity | NPD1876 | Approved |
0.7059 | Intermediate Similarity | NPD4287 | Approved |
0.7052 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7052 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD5890 | Approved |
0.7051 | Intermediate Similarity | NPD5889 | Approved |
0.7044 | Intermediate Similarity | NPD955 | Approved |
0.7042 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7027 | Intermediate Similarity | NPD5406 | Approved |
0.7027 | Intermediate Similarity | NPD5405 | Approved |
0.7027 | Intermediate Similarity | NPD5408 | Approved |
0.7027 | Intermediate Similarity | NPD5404 | Approved |
0.702 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7012 | Intermediate Similarity | NPD3751 | Discontinued |
0.7011 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7008 | Intermediate Similarity | NPD846 | Approved |
0.7008 | Intermediate Similarity | NPD940 | Approved |
0.7 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD290 | Approved |
0.6986 | Remote Similarity | NPD1184 | Approved |
0.6978 | Remote Similarity | NPD1091 | Approved |
0.6974 | Remote Similarity | NPD7440 | Discontinued |
0.6966 | Remote Similarity | NPD520 | Approved |
0.6966 | Remote Similarity | NPD6233 | Phase 2 |
0.6964 | Remote Similarity | NPD8312 | Approved |
0.6964 | Remote Similarity | NPD8313 | Approved |
0.6963 | Remote Similarity | NPD6671 | Approved |
0.6954 | Remote Similarity | NPD7003 | Approved |
0.6943 | Remote Similarity | NPD2366 | Approved |
0.6937 | Remote Similarity | NPD6971 | Discontinued |
0.6929 | Remote Similarity | NPD1242 | Phase 1 |
PubChem CID   | 68112 |
ChEMBL   | CHEMBL16807 |
ZINC   |
Molecular Weight:   | 238.06 |
ALogP:   | -0.9639 |
MLogP:   | 2.78 |
XLogP:   | 4.126 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 46.53 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 18 |